 |
 |
Product ID |
Structure |
Product Name |
Purity |
Price |
Delete |
JR6-L7117 |
 |
1,2-Ethanediol, 1,2-bis([1,1'-biphenyl]-4-yl)-, [R-(R*,R*)]- (9CI) |
96%
|
|
Delete |
JR6-L7127 |
 |
1,2-Ethanediol, 1,2-bis(3,4,5-trifluorophenyl)-, (1R,2R)- |
96%
|
|
Delete |
JR6-L3754 |
 |
1H-Imidazole-4-butanol, 1-(triphenylmethyl)- |
96%
|
|
Delete |
JR6-L3582 |
 |
1H-Isoindole-1,3(2H)-dione, 2-(4-aminobutyl)- |
96%
|
|
Delete |
AS-5343 |
 |
2,4-Dinitrobenzaldehyde |
98%
|
|
Delete |
A1-0419 |
 |
2-Chloro-3-nitro-4-picoline |
98%
|
10g/$250 |
Delete |
AS-7158 |
 |
2-Chloro-5-fluorophenol |
98%
|
|
Delete |
AS-0604 |
 |
2-Methoxy-5-nitro-3-picoline |
98%
|
|
Delete |
JR6-L6763 |
 |
3H-Pyrazol-3-one, 2-(2-chlorophenyl)-2,4-dihydro-5-(trifluoromethyl)- |
96%
|
$580/1g, $980/2g, $1980/5g |
Delete |
JR6-L3567 |
 |
4-(2-hydroxyethyl)azetidin-2-one |
96%
|
|
Delete |
AS-7862 |
 |
4-(BROMOMETHYL)-2-FLUOROBENZONITRILE |
98%
|
|
Delete |
AS-4657 |
 |
5-Fluoro-2-nitroaniline |
98%
|
|
Delete |
AS-2962 |
 |
5-Methyl-1H-pyrazole-3-carboxylic acid |
98%
|
|
Delete |
JR6-L2428 |
 |
Benzenemethanol, 3,5-dimethyl-a-(trifluoromethyl)- |
96%
|
$398/1g, $1280/5g, $4980/25g |
Delete |
JR8-N0959 |
 |
Benzoic acid |
98%
|
|
Delete |
JR6-L5111 |
 |
Benzoic acid, 4-[[(3,4-dimethoxyphenyl)(2-methyl-1H-indol-3-yl)methyl]amino]-, ethyl ester |
96%
|
|
Delete |
JR6-L2705 |
 |
Carbamic acid, N-[(1R)-1-[(2S)-2-oxiranyl]-2-phenylethyl]-, 1,1-dimethylethyl ester |
96%
|
$980/1g, $2480/5g, 10g/$4480, $7980/25g |
Delete |
JR8-N0056 |
 |
Cryptotanshinone |
98%
|
$98/100mg, 500mg/$398, 1g/$518, 5g |
Delete |
JR6-L7149 |
 |
Oxazole |
96%
|
|
Delete |
JR6-L3569 |
 |
Propanenitrile, 3-(triphenylmethoxy)- |
96%
|
|
Delete |
JR6-L4715 |
 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 3,4-dihydro-4-oxo-6-(4-pyridinyl)-, 1,1-dimethylethyl ester |
96%
|
|
Delete |
JR6-L4713 |
 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 3,4-dihydro-7-(4-morpholinyl)-4-oxo-, 1,1-dimethylethyl ester |
96%
|
|
Delete |
Continue browsing products
Quote/Order
Inquiry
|
|
|
 |
 |
 |